Leveraging the continual understanding of disease with advanced technologies showed a significant and increasing portion of high potent drugs in pharmaceutical industry. These include targeted drugs, chemotherapeutics and cytotoxic agents conjugated to delivery molecules. The percentage of these drugs currently contribute around 25% of global pharmaceutical development pipeline.

for more details visit https://www.linkedin.com/pulse/opportunities-challenges-high-potency-active-process-muni-bhaskar/?trackingId=HBTy0zaURyuV83%2FWWxRsug%3D%3D